Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Meta Platforms
META
Adobe
ADBE
US Stock MarketDetailed Quotes
IMVT Immunovant
- 24.490
- -1.240-4.82%
Close Dec 27 16:00 ET
- 24.490
- 0.0000.00%
Post 20:01 ET
3.59BMarket Cap-11.08P/E (TTM)
25.620High23.910Low1.16MVolume25.470Open25.730Pre Close28.53MTurnover1.77%Turnover RatioLossP/E (Static)146.78MShares45.58052wk High8.01P/B1.61BFloat Cap23.91052wk Low--Dividend TTM65.66MShs Float53.750Historical High--Div YieldTTM6.65%Amplitude3.145Historical Low24.510Avg Price1Lot Size
About Immunovant Company
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.
Company Profile
SymbolIMVT
Company NameImmunovant
Founded2018
CEODr. Peter Salzmann, M.B.A.,M.D.
MarketNASDAQ
Employees207
Fiscal Year Ends03-31
Address320 West 37th Street,6th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10018
Phone1-917-580-3099
Websitehttp://www.immunovant.com
Company Executives
- Name
- Position
- Salary
- Dr. Peter Salzmann, M.B.A.,M.D.
- Director and Chief Executive Officer
- 8.55M
- Dr. Julia G. Butchko, PhD
- Chief Development Officer
- 3.71M
- Dr. Jay S. Stout, PhD
- Chief Technology Officer
- 4.04M
- Eva Renee Barnett, M.B.A.
- Chief Financial and Accounting Officer
- --
- Mark S. Levine
- Chief Legal Officer and Corporate Secretary
- --
- Dr. William L. Macias, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Frank M. Torti, M.D.
- Executive Chairman of the Board
- 3.69M
- Andrew J. Fromkin
- Director
- 445.00K
- Dr. Eric Venker, M.D.,Pharm.D.
- Director
- 55.00K
- Dr. Atul Pande, M.D.
- Independent Director
- 433.80K
- Douglas J. Hughes
- Independent Director
- 436.30K
- George V. Migausky
- Independent Director
- 437.50K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.